Editas Medicine, Inc. (EDIT) Free cash flow 2016–2025
Editas Medicine, Inc. (EDIT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$165.8MFY2025 · since FY2016: -$53.7M → -$165.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$165.8M | +24.3% |
| FY2024 | -$219.1M | -60.1% |
| FY2023 | -$136.9M | +24.6% |
| FY2022 | -$181.5M | -5.6% |
| FY2021 | -$171.8M | +8.1% |
| FY2020 | -$187.0M | -299.3% |
| FY2019 | -$46.8M | +7.2% |
| FY2018 | -$50.5M | -339.7% |
| FY2017 | -$11.5M | +78.6% |
| FY2016 | -$53.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice